Past Conference Reports

C2P Forum is pleased to announce the successful completion of the European Congress on Rare Diseases and Orphan Drugs, held on November 17-18, 2025, in Rome, Italy.

The conference, themed “Pioneering Care for the Few: Novel Insights into Rare Diseases and Orphan Therapies,” concluded with great success.

We extend our sincere gratitude to the esteemed scientists, distinguished researchers, students and professionals from universities, research institutions, companies, and laboratories worldwide who contributed their latest insights and expertise in the field of Climate change and environmental sustainability.

The conference featured a dynamic program, including keynote addresses, oral presentations, poster sessions, and video presentations. The event was marked by significant engagement and outstanding contributions, and we are delighted to share some of the key highlights presented during the sessions:

• J Paul Seale, Augusta University, USA
•  Joan-Lluis Vives Corrons, Josep Carreras Leukaemia Research Institute, Spain
• Jorge Sales Marques, Hospital Cuf Porto, Portugal
• Deovrat N Begde, Ambedkar College, India
• Agata Kulkowska-Gaj, University of Opole, Poland
• Tiziana Patrizia Cremona, University of Bern, Switzerland
• Mélissa Bou-Jaoudeh, ProductLife Group, France
• Sara Dei, University of Verona & University of Naples Parthenope, Italy
• Shami Pokhrel, Lumbini Medical College, Nepal
• Tiia Matsi, Addiction Psychiatrist, Finland
• Soo Hyeon Cho, Korea Disease Control and Prevention Agency (KDCA) & Yonsei University, South Korea
• Boris Sevarika, University of Basel, Switzerland
•  Jingzhen Ginger Yang, Nationwide Children’s Hospital, USA
• Hind Ghannam Alruwaili, King Abdulaziz University, Saudi Arabia
• Kele Ding, Kent State University & Nationwide Children’s Hospital, USA
• Osama Alanazi, King Abdulaziz University, Saudi Arabi
• Mona Mokhtarnejad, Islamic Azad University of Urmia, Iran
• Arwa M Mahasneh, Queen Mary University of London, UK
• Margaret A Kadree, Virginia Department of Health, USA
• Ranko Stevanović, Croatian Society for Harm Reduction in Public Health (HaRPH), Croatia
• Margarita C Dinamarca, University of Basel, Switzerland
• Ina Barzel, Erasmus University Medical Center, Netherlands
• Mariam Ahmed Abu Alim, Yarmouk University, Jordan
• Jorge Emilio Salazar Flórez, San Martín University Foundation, Colombia
• Ilaria Svezia, Bambino Gesù Children’s Hospital & University of Rome Tor Vergata, Italy
• Seyma Akarsu, Istanbul Technical University, Turkey
• Karin Schmid, Alpha-1 Patient Organization, Switzerland
• Gulsen Meral, Nisantasi University, Turkey & Epigenetic Coaching, UK
• Juliana Diniz José, Amazone-se, Brazil
• Donatella Capone, NAnA ETS, Italy
• Karin Schmid, Alpha-1 Patient Organization, Switzerland

We would like to express our sincere appreciation to our Session Chairs J Paul Seale, Augusta University, USA, Jorge Sales Marques, Hospital Cuf Porto, Portugal, Gulsen Meral, Nisantasi University, Turkey & Epigenetic Coaching, UK

Building on the success of the Euro Rare Diseases 2025, we are pleased to announce our upcoming event, 2^nd European Congress on Rare Diseases and Orphan Drugs on September 14-15, 2026 in London, UK

More info: https://rarediseases.c2pforum.com/

Huge thanks to all the delegates! Your energy and involvement made this event a big success!

Mark your calendars and set your reminders.

Hope to meet you again in London, UK!!